Repository logo
 

The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Bloor, Stuart 
Williamson, James C 
Cuesta, Sergio Martínez 
Shah, Raven 

Abstract

Silencing of nuclear DNA is an essential feature of innate immune responses to invading pathogens. Early in infection, unintegrated lentiviral cDNA accumulates in the nucleus yet remains poorly expressed. In HIV-1-like lentiviruses, the Vpr accessory protein enhances unintegrated viral DNA expression, suggesting Vpr antagonizes cellular restriction. We previously showed how Vpr remodels the host proteome, identifying multiple cellular targets. We now screen these using a targeted CRISPR-Cas9 library and identify SMC5-SMC6 complex localization factor 2 (SLF2) as the Vpr target responsible for silencing unintegrated HIV-1. SLF2 recruits the SMC5/6 complex to unintegrated lentiviruses, and depletion of SLF2, or the SMC5/6 complex, increases viral expression. ATAC-seq demonstrates that Vpr-mediated SLF2 depletion increases chromatin accessibility of unintegrated virus, suggesting that the SMC5/6 complex compacts viral chromatin to silence gene expression. This work implicates the SMC5/6 complex in nuclear immunosurveillance of extrachromosomal DNA and defines its targeting by Vpr as an evolutionarily conserved antagonism.

Description

Keywords

ATAC-seq, CRISPR-Cas9 knockout screen, Extrachromosomal DNA, HIV-1, SLF2, SMC5-SMC6 complex, Vpr, chromatin compaction, unintegrated lentivirus, viral gene silencing, Cell Cycle Proteins, Chromosomal Proteins, Non-Histone, HIV Infections, HIV-1, Host-Pathogen Interactions, Humans, Ubiquitin-Protein Ligases, Virus Integration, Virus Replication, vpr Gene Products, Human Immunodeficiency Virus

Journal Title

Cell Host Microbe

Conference Name

Journal ISSN

1931-3128
1934-6069

Volume Title

29

Publisher

Elsevier BV
Sponsorship
Wellcome Trust (210688/Z/18/Z)
Wellcome Trust (109074/Z/15/Z)
Wellcome Trust (209441/Z/17/Z)
Addenbrooke's Charitable Trust (ACT) (Minute 42/18 C3)
Medical Research Council (MR/P008801/1)
MRC (MR/V011561/1)